The pooled SMD was 0.81 (95% CI: 0.21‐1.40; P = .008), indicating that the level of IL‐6 (Figure 2A) in the peripheral blood of glioma patients was significantly higher than that of the normal control group. The gene discussed is IL6; the disease is glioma.